Goldman Sachs Initiates Coverage On Riskified with Sell Rating, Announces Price Target of $9
Goldman Sachs analyst Will Nance initiates coverage on Riskified (NYSE:RSKD) with a Sell rating and announces Price Target of $9.
Where Riskified Stands With Analysts
Within the last quarter, Riskified (NYSE:RSKD) has observed the following analyst ratings:
80 Biggest Movers From Yesterday
Gainers
BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a narrower Q3 loss.
53 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
BIMI International Medical Inc. (NASDAQ: BIMI) jumped 65.7% to $1.0691 as the company reported a narrower Q3 loss.
Riskified Q3 EPS $(0.08) Beats $(0.38) Estimate, Sales $52.53M Beat $51.03M Estimate
Riskified (NYSE:RSKD) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.38) by 78.95 percent. The company reported quarterly sales of $52.53 million which beat the analyst
Earnings Scheduled For November 16, 2021
Companies Reporting Before The Bell
• Ozon Holdings (NASDAQ:OZON) is expected to report quarterly loss at $0.90 per share on revenue of $602.00 million.
Keybanc Maintains Overweight on Riskified, Lowers Price Target to $25
Keybanc analyst Josh Beck maintains Riskified (NYSE:RSKD) with a Overweight and lowers the price target from $35 to $25.
45 Stocks Moving In Monday’s Mid-Day Session
Gainers
Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets.